ENDRA Life Sciences Inc. has completed a private placement offering, issuing a total of 744,340 shares of common stock or prefunded warrants in lieu thereof, alongside warrants to purchase up to 1,488,680 shares of common stock. The warrants carry an exercise price of $6.32 per share, or $6.81 for warrants purchased by a board member. The offering generated approximately $4.9 million in gross proceeds. This transaction was part of the company's strategy to regain compliance with the Nasdaq minimum stockholders' equity requirement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-110897), on November 14, 2025, and is solely responsible for the information contained therein.